Literature DB >> 1709107

Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123.

C Udomsakdi1, C J Eaves, H J Sutherland, P M Lansdorp.   

Abstract

Normal human bone marrow (BM) contains a small population of cells that can give rise to clonogenic progenitors after 5 weeks in long-term culture (LTC). We have previously shown that these LTC-initiating cells (LTC-IC) differ from the majority of directly clonogenic cells with respect to both light-scattering properties and surface antigen expression. In this paper we show that virtually all LTC-IC (94%) are among the 3%-5% of light-density marrow cells that take up relatively low amounts of rhodamine-123 (Rh-123). In contrast, only 70% of erythroid burst-forming units (BFU-E) and 40% of granulocyte-macrophage colony-forming units (CFU-GM) are recovered in the Rh-123-dull fraction. In addition, we have found that double staining of marrow with Rh-123 and phycoerythrin-labeled anti-CD34 antibodies allows the CD34+ cells to be divided into two subpopulations, of which, on average, 35% are Rh-123-dull. Isolation of these CD34+ Rh-123-dull cells thus provides a single-step enrichment of approximately 240-fold in LTC-IC by comparison to the light-density (less than 1.077 g/cm3) fraction of normal BM. This represents an overall enrichment in LTC-IC of approximately 1000-fold. As expected from the results of staining with Rh-123 only, the majority of directly clonogenic cells are present in the CD34+ Rh-123-bright fraction, where they are enriched approximately 40-fold over their concentration in the light-density fraction. These results indicate marked differences in Rh-123 uptake between subsets of primitive human hematopoietic cells currently defined by different functional assays and suggest that RH-123 staining will be useful for the further purification and analysis of these cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709107

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  14 in total

Review 1.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 2.  Cancer stem cell detection and isolation.

Authors:  Meysam Moghbeli; Faezeh Moghbeli; Mohammad Mahdi Forghanifard; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

3.  High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.

Authors:  N Uchida; A Tsukamoto; D He; A M Friera; R Scollay; I L Weissman
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.

Authors:  C Udomsakdi; C J Eaves; B Swolin; D S Reid; M J Barnett; A C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  Isolation and applications of prostate side population cells based on dye cycle violet efflux.

Authors:  Kalyan J Gangavarpu; Wendy J Huss
Journal:  Curr Protoc Toxicol       Date:  2011-02

Review 6.  Modeling human hematopoietic stem cell biology in the mouse.

Authors:  Stephen M Sykes; David T Scadden
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

7.  Isolation of a candidate human hematopoietic stem-cell population.

Authors:  C M Baum; I L Weissman; A S Tsukamoto; A M Buckle; B Peault
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics.

Authors:  R L Phillips; A J Reinhart; G Van Zant
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

9.  Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells.

Authors:  Vera S Donnenberg; E Michael Meyer; Albert D Donnenberg
Journal:  Methods Mol Biol       Date:  2009

10.  Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents.

Authors:  Vera S Donnenberg; Rodney J Landreneau; Albert D Donnenberg
Journal:  J Control Release       Date:  2007-05-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.